BioSpace News Archive

Study published in Cell demonstrates causal link between seizure susceptibility and the microbiome, identifies gut bacteria that confer anti-seizure effects

VitalConnect®, Inc., a leader in wearable biosensor technology for wireless monitoring in hospital and remote patient populations, today announced the addition of chief marketing officer Joe Lynch.

Spinal Elements, a spine technology company, today announced the release of its Clutch interspinous process device.

Today, DotLab announces that a new longitudinal study has been initiated at the Yale School of Medicine to validate its non-invasive blood and saliva tests for endometriosis.

3rd approval for Plant 2 in just 26 months since GMP ready

LabConnect, LLC has completed phase one of an 11,000+ square foot facility expansion in Johnson City, Tennessee.

DSUVIA PDUFA date set for November 3, 2018

Announced the expansion of its ongoing Phase I/IIa clinical trial for OpRegen®, with the addition of two new U.S. sites that are expected to begin treating patients later this quarter.

Median overall survival was 33.4 months compared to 27.6 months in the ESPAC4 trial

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the company will be exhibiting and participating at Digestive Disease Week (DDW), which is taking place from June 2-5, 2018 at the Walter E. Washington Convention Center in Washington, DC.